Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
BiondVax Pharmaceuticals announced a patent covering production processes of the Company's M-001 universal influenza vaccine candidate was allowed in the USA and Japan.
read more
Friday, December 11, 2020
Passage Bio and Catalent announced manufacturing operations have commenced to support AAV production for Passage Bio’s lead gene therapy product candidates for the treatment of rare monogenic CNS disorders.
read more
Passage Bio has entered into a collaboration agreement with Paragon Gene Therapy for the development of a dedicated manufacturing suite at their facility near Baltimore.
read more
Particle Sciences is opening a new commercial drug product manufacturing facility at the end of 2018 at its existing site in Bethlehem, PA.
read more
Monday, November 18, 2019
Lubrizol has announced that its CDMO, Particle Sciences, is to be renamed Lubrizol Life Science Health.
read more
Thursday, September 13, 2018
Particle Sciences has announced the appointment of Dr. Robert Lee to president.
read more
Wednesday, March 13, 2019
Particle Sciences has announced the appointment of Karen Bossert as vice president of operations as part of its ongoing strategy to grow and enhance its manufacturing capabilities.
read more
Wednesday, August 12, 2015
Dr Nick Hutchinson from Parker domnick hunter, will be delivering a presentation at BioProduction 2015 about quality by design (QbD) and how it can be integrated into a bioprocess to ensure control over the post approval life cycle management plan.
read more
Tuesday, February 18, 2014
As the global biopharmaceutical industry increasingly seeks to streamline the complex process of bringing new drugs to market, PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the...
read more
Friday, February 04, 2022
Medidata, a Dassault Systèmes company, announced that Parexel is extending their 15-year global strategic partnership. This builds upon the trusted relationship between the two companies and sets the goal of jointly pioneering a new era of ...
read more
Wednesday, February 13, 2019
PAREXEL announced the appointment of four former senior executives from the FDA to its Regulatory Consulting group.
read more
Parexel unveiled its COVID-19 Risk Mitigation offering, which leverages the company’s experience with global viral outbreaks as well as cGMP inspection and CMC review processes to ensure that manufacturers can safely and confidently continue ...
read more
Parexel has unveiled its COVID-19 Risk Mitigation offering, which leverages the company’s experience with global viral outbreaks.
read more
Paratek Pharmaceuticals, Inc. announced the receipt of a $36.4 million milestone payment associated with the second procurement of NUZYRA® (omadacycline) under the company’s Project BioShield contract with the Biomedical Advanced Research and ...
read more
Paratek announced BARDA has initiated funding to support the onshoring of Paratek manufacturing activities for NUZYRA.
read more